Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» primary biliary cirrhosis
primary biliary cirrhosis
Intercept Wins FDA Approval for Drug to Treat Liver Disease
Bloomberg
Mon, 05/30/16 - 10:08 am
Intercept Pharma
FDA
Ocaliva
obeticholic acid
primary biliary cirrhosis
FDA advisory panel supports quick approval for Intercept's drug OCA for liver disease
Fierce Biotech
Thu, 04/7/16 - 09:40 pm
FDA
advisory panels
Intercept Pharma
OCA
primary biliary cirrhosis
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
Yahoo
Mon, 08/31/15 - 08:26 am
FDA
Intercept Pharma
obeticholic acid
priority review
primary biliary cirrhosis
Intercept Announces Positive Pivotal Phase 3 POISE Trial Results
Yahoo/Globe Newswire
Sun, 03/16/14 - 11:46 am
Intercept Pharma
obeticholic acid
primary biliary cirrhosis
Intercept to Provide Update on Pipeline
Yahoo/Zacks.com
Mon, 01/6/14 - 04:49 pm
Intercept Pharma
primary biliary cirrhosis
Intercept OCA likely to qualify for accelerated approval, says Oppenheimer
Yahoo/Fly on the Wall
Thu, 07/11/13 - 10:34 am
Intercept Pharma
OCA
primary biliary cirrhosis